Invesaro

Stocks AFJK Financial statements

Financial statements

Aimei Health Technology Co., Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 2 fiscal years, taken from the XBRL data Aimei Health Technology Co., Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2024FY2025
Operating income-1.06-0.84
Other non-operating income3.621.9
Income tax00
Net income2.551.06

Balance sheet

FY2024FY2025
Cash and equivalents0.030
Other current assets0
Total current assets0.030
Total assets73.812.1
Accrued liabilities0.30.45
Total current liabilities0.823.37
Total liabilities1.514.06
Retained earnings-1.48-4.06
Shareholders' equity-1.48-4.06
Total equity-1.48-4.06
Total liabilities and equity73.812.1
Shares outstanding2.132.13

Cash flow statement

FY2024FY2025
Net income2.551.06
Cash from operations-0.67-0.57
Cash from investing-0.2863.6
Share buybacks-65.3
Cash from financing0.4-63
Net change in cash-0.55-0.03

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $12.19 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Return on assets (ROA)3.3%Net income / average total assets.

Growth

MetricValueHow it is calculated
Net income growth, 1y-58.5%Net income vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-83.6%Total assets vs the same period a year earlier. Only from a positive base.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.01xCurrent assets / current liabilities.
Quick ratio0.00x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.00x(Cash + short-term investments) / current liabilities.
Liabilities / assets36.1%Total liabilities / total assets.
Working capital-$3.8MCurrent assets - current liabilities.
Tangible book value-$4.5MShareholders' equity - goodwill - intangible assets.

Per share

MetricValueHow it is calculated
Book value per share-$2.11Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$2.11Tangible book value / shares outstanding.
Cash per share$0.00(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$38.6MShare price x shares outstanding.
Enterprise value$38.6MMarket cap + total debt - cash - short-term investments.
P/E93.6xMarket cap / net income. Only when net income is positive.
Earnings yield1.1%Net income / market cap (the inverse of P/E).
Was Aimei Health Technology Co., Ltd. profitable in fiscal 2025?

Yes. Net income was $1.1M, a net margin of -.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Aimei Health Technology Co., Ltd.